Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms

被引：3

作者：

Patnaik, Mrinal M. ^{[1
]}

Zeidan, Amer M. ^{[2
,3
]}

Padron, Eric ^{[4
]}

Platzbecker, Uwe ^{[5
]}

Sallman, David A. ^{[4
]}

DeZern, Amy E. ^{[6
,7
]}

Bejar, Rafael ^{[8
]}

Sekeres, Mikkael ^{[9
]}

Taylor, Justin ^{[9
]}

Little, Richard F. ^{[10
]}

Bewersdorf, Jan P. ^{[11
]}

Kim, Tae Kon. ^{[12
]}

Kim, Nina ^{[10
]}

Hourigan, Christopher S. ^{[10
]}

Dela Porta, Matteo G. ^{[13
,14
]}

Stahl, Maximilian ^{[15
,16
]}

Steensma, David ^{[17
]}

Xu, Mina L. ^{[3
,18
,19
]}

Odenike, Olatoyosi ^{[20
]}

Carraway, Hetty ^{[21
]}

Fenaux, Pierre ^{[22
,23
]}

Nazha, Aziz ^{[24
]}

Komrokji, Rami ^{[4
]}

Loghavi, Sanam ^{[25
]}

Xie, Zhuoer ^{[4
]}

Hasserjian, Robert ^{[26
]}

Savona, Michael ^{[12
]}

Bennett, John M. ^{[27
]}

机构：

[1] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA

[2] Yale Univ, Sch Med, Dept Internal Med, Sect Hematol, New Haven, CT 06510 USA

[3] Yale Canc Ctr, New Haven, CT USA

[4] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol, Tampa, FL USA

[5] Univ Leipzig, Dept Hematol, Leipzig, Germany

[6] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Div Hematol Malignancies, Baltimore, MD USA

[7] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Oncol, Baltimore, MD USA

[8] Univ Calif San Diego, Moores Canc Ctr, Div Hematol & Oncol, La Jolla, CA USA

[9] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA

[10] NCI, NIH, Bethesda, MD 20892 USA

[11] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA

[12] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Hematol, Nashville, TN 37212 USA

[13] Humanitas Clin & Res Ctr, Milan, Italy

[14] Humanitas Univ, Dept Biomed Sci, Milan, Italy

[15] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[16] Harvard Med Sch, Boston, MA 02115 USA

[17] Novartis Inst Blood Res, Boston, MA USA

[18] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA

[19] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06510 USA

[20] Univ Chicago Med, Hematol Oncol Sect, Chicago, IL USA

[21] Cleveland Clin, Taussig Canc Inst, Leukemia Program, Cleveland, OH 44106 USA

[22] Hop St Louis, Assistance Publ Hop Paris, Paris, France

[23] Univ Paris Cite, Paris, France

[24] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Med Oncol, Philadelphia, PA 19107 USA

[25] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[26] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA

[27] Univ Rochester, Med Ctr, Dept Med Pathol & Lab Med, Rochester, NY 14642 USA

来源：

LEUKEMIA | 2022年 / 36卷 / 12期

关键词：

HEALTH-ORGANIZATION CLASSIFICATION; REVISION; LEUKEMIA;

D O I：

10.1038/s41375-022-01754-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2934 / 2938

页数：5

共 50 条

[11] Advances in myelodysplastic/myeloproliferative neoplasms
Sonam Prakash
Daniel A. Arber
Carlos Bueso-Ramos
Robert P. Hasserjian
Attilio Orazi
Virchows Archiv, 2023, 482 : 69 - 83
[12] Changed concepts and definitions of myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in the updated 2008 WHO classification
Hebeda K.M.
Fend F.
Journal of Hematopathology, 2009, 2 (4) : 205 - 210
[13] Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms
Buettner-Herold, Maike
Sticht, Carsten
Wiech, Thorsten
Porubsky, Stefan
HISTOPATHOLOGY, 2021, 78 (05) : 738 - 748
[14] The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features
Orazi, A.
Germing, U.
LEUKEMIA, 2008, 22 (07) : 1308 - 1319
[15] The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features
A Orazi
U Germing
Leukemia, 2008, 22 : 1308 - 1319
[16] Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
Cazzola, Mario
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (03): : 349 - 352
[17] Turning the tide in myelodysplastic/myeloproliferative neoplasms
Michael W. N. Deininger
Jeffrey W. Tyner
Eric Solary
Nature Reviews Cancer, 2017, 17 : 425 - 440
[18] Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms
Palomo, Laura
Acha, Pamela
Sole, Francesc
CANCERS, 2021, 13 (09)
[19] Turning the tide in myelodysplastic/myeloproliferative neoplasms
Deininger, Michael W. N.
Tyner, Jeffrey W.
Solary, Eric
NATURE REVIEWS CANCER, 2017, 17 (07) : 425 - 440
[20] Molecular basis of myelodysplastic/myeloproliferative neoplasms
Reiter, Andreas
Invernizzi, Rosangela
Cross, Nicholas C. P.
Cazzola, Mario
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (12): : 1634 - 1638

← 1 2 3 4 5 →